HIV Protein Strikes a Fleeting Pose

News   Aug 03, 2012

 
HIV Protein Strikes a Fleeting Pose
 
 
 

RELATED ARTICLES

CMC Biologics Announces Development and Manufacturing Agreement with Harpoon Therapeutics

News

Companies have entered into agreement for the development and manufacturing of three TriTAC molecules for the treatment of cancers.

READ MORE

Tailor-made Protein Fights Several Species of Bacteria

News

As resistance to existing antibiotics increases, new approaches to serious bacterial infections are needed. Now researchers have investigated one such alternative.

READ MORE

First Successful Gene Therapy Trial Reported for People with Hemophilia A

News

Patients with hemophilia A who received a single infusion of an investigational gene therapy showed improved levels of the essential blood clotting protein FVIII, with 11 of 13 achieving normal or near-normal FVIII levels.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE